Opna Bio
Phase 1Company Opna Bio develops drugs targeting the Hallmarks of Cancer.
Founded
2021
Focus
OncologyImmunology
About
Company Opna Bio develops drugs targeting the Hallmarks of Cancer.
Funding History
1Total raised: $3.5M
Seed$3.5MUndisclosedSep 15, 2021
Company Info
TypePrivate
Founded2021
LocationBasel, Switzerland
StagePhase 1
Contact
SIMILAR COMPANIES
3Brain
Pre-clinical · Zug
Baxiva
Pre-clinical · Zug
AC Bioscience
Pre-clinical · Lausanne
Abrinca Genomics
Pre-clinical · Zurich
AdipoGen
Pre-clinical · Liestal
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile